|
Volumn 22, Issue 8, 2004, Pages 228-231
|
The benefits of fourth generation fluoroquinolones in the prevention of ocular infections
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CIPROFLOXACIN;
GATIFLOXACIN;
GREPAFLOXACIN;
I QUIX;
LEVOFLOXACIN;
LOMEFLOXACIN;
MOXIFLOXACIN;
NALIDIXIC ACID;
NORFLOXACIN;
OFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SPARFLOXACIN;
ANTIBIOTIC SENSITIVITY;
AREA UNDER THE CURVE;
CONFERENCE PAPER;
DRUG ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG INDICATION;
ENDOPHTHALMITIS;
EYE INFECTION;
HUMAN;
KERATITIS;
KERATOMILEUSIS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
TOXICITY;
TREATMENT OUTCOME;
|
EID: 9344235417
PISSN: 17054842
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|